Target
Beta-catenin-interacting protein 1
Ligand
BDBM269259
Substrate
n/a
Meas. Tech.
Idiopathic Pulmonary Fibrosis (IPF) Primary Screening Assay
IC50
1900±n/a nM
Citation
 Hood, JKC, SKWallace, DM 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof US Patent  US10071086 Publication Date 9/11/2018 
Target
Name:
Beta-catenin-interacting protein 1
Synonyms:
CNBP1_HUMAN | CTNNBIP1 | ICAT | Inhibitor of beta-catenin and Tcf-4
Type:
Enzyme Catalytic Domain
Mol. Mass.:
9168.75
Organism:
Homo sapiens (Human)
Description:
Q9NSA3
Residue:
81
Sequence:
MNREGAPGKSPEEMYIQQKVRVLLMLRKMGSNLTASEEEFLRTYAGVVNSQLSQLPPHSIDQGAEDVVMAFSRSETEDRRQ
  
Inhibitor
Name:
BDBM269259
Synonyms:
US10071086, Compound 7
Type:
Small organic molecule
Emp. Form.:
C25H19FN8
Mol. Mass.:
450.4704
SMILES:
CN(C)c1cncc(c1)-c1cnc2[nH]nc(-c3nc4c(cncc4[nH]3)-c3cccc(F)c3)c2c1
Structure:
Search PDB for entries with ligand similarity: